Patents by Inventor Tengjiao Wang

Tengjiao Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biocampatible and Biodegradable Anionic Hydrogel System
    Publication number: 20230241228
    Abstract: An anionic hydrogel for wound healing comprised of poly(oligoethylene glycol monoacrylate), acrylic, a neutral species and a wild-type fibroblast growth factor 1 (wtFGF1).
    Type: Application
    Filed: April 10, 2023
    Publication date: August 3, 2023
    Applicant: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Jingyi Chen, Tengjiao Wang, Isabelle Niyonshuti, Suresh Kumar Thallapuranam, Ravi K. Gundampati, Shilpi Agrawal, Kyle P. Quinn, Jake D. Jones
  • ENGINEERED FGF1 AND FGF2 COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20220227826
    Abstract: Engineered FGF1 and FGF2 polypeptides, polynucleotides encoding these polypeptides and DNA constructs, vectors and compositions including these engineered polypeptides are provided herein. The engineered FGF1 and FGF2 polypeptides are more stable than their wild-type counterparts and may be more effective at treating a variety of conditions that FGF1 and FGF2 are useful for treating such as wound healing.
    Type: Application
    Filed: January 28, 2022
    Publication date: July 21, 2022
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Suresh Kumar Thallapuranam, Shilpi Agrawal, Ravi Kumar Gundampati, Srinivas Jayanthi, Tengjiao Wang, Jake Jones, Olivia Kolenc, Ngoc Lam, Isabelle Niyonshuti, Kartik Balachandran, Kyle Quinn, Jingyi Chen
  • Engineered FGF1 and FGF2 compositions and methods of use thereof
    Patent number: 11267855
    Abstract: Engineered FGF1 and FGF2 polypeptides, polynucleotides encoding these polypeptides and DNA constructs, vectors and compositions including these engineered polypeptides are provided herein. The engineered FGF1 and FGF2 polypeptides are more stable than their wild-type counterparts and may be more effective at treating a variety of conditions that FGF1 and FGF2 are useful for treating such as wound healing.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: March 8, 2022
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Suresh Kumar Thallapuranam, Shilpi Agarwal, Ravi Kumar Gundampati, Srinivas Jayanthi, Tengjiao Wang, Jake Jones, Olivia Kolenc, Ngoc Lam, Isabelle Niyonshuti, Kartik Balachandran, Kyle Quinn, Jingyi Chen
  • Biocampatible and Biodegradable Anionic Hydrogel System
    Publication number: 20210170038
    Abstract: An anionic hydrogel based on poly(acrylic acid)-co-poly(oligoethylene glycol monoacrylate) (PAA-co-POEGA) for protein delivery and method of making the same.
    Type: Application
    Filed: February 23, 2021
    Publication date: June 10, 2021
    Applicant: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Jingyi Chen, Tengjiao Wang, Isabelle Niyonshuti, Suresh Kumar Thallapuranam, Ravi K. Gundampati, Shilpi Agrawal, Kyle P. Quinn, Jake D. Jones
  • Biocampatible and Biodegradable Anionic Hydrogel System
    Publication number: 20190343959
    Abstract: An anionic hydrogel based on poly(acrylic acid)-co-poly(oligoethylene glycol monoacrylate) (PAA-co-POEGA) for protein delivery and method of making the same.
    Type: Application
    Filed: May 10, 2019
    Publication date: November 14, 2019
    Applicant: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Jingyi Chen, Tengjiao Wang, Isabelle Niyonshuti, Suresh Kumar Thallapuranam, Ravi K. Gundampati, Shilpi Agrawal, Kyle P. Quinn, Jake D. Jones
  • ENGINEERED FGF1 AND FGF2 COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20190284252
    Abstract: Engineered FGF1 and FGF2 polypeptides, polynucleotides encoding these polypeptides and DNA constructs, vectors and compositions including these engineered polypeptides are provided herein. The engineered FGF1 and FGF2 polypeptides are more stable than their wild-type counterparts and may be more effective at treating a variety of conditions that FGF1 and FGF2 are useful for treating such as wound healing.
    Type: Application
    Filed: March 18, 2019
    Publication date: September 19, 2019
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Suresh Kumar Thallapuranam, Shilpi Agarwal, Ravi Kumar Gindampati, Srinivas Jayanthi, Tengjiao Wang, Jake Jones, Olivia Kolenc, Ngoc Lam, Isabelle Niyonshuti, Kartik Balachandran, Kyle Quinn, Jingyi Chen